Trials / Completed
CompletedNCT00263055
MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV
Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Safety \& tolerability of FOLFOX4 regimen in the adjuvant treatment of colon cancer in Asian patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oxaliplatin |
Timeline
- Start date
- 2004-08-01
- Primary completion
- 2005-06-01
- First posted
- 2005-12-07
- Last updated
- 2009-09-15
Locations
5 sites across 5 countries: China, Hong Kong, South Korea, Taiwan, Thailand
Source: ClinicalTrials.gov record NCT00263055. Inclusion in this directory is not an endorsement.